Skip to main content
. 2018 Dec 23;20(1):57. doi: 10.3390/ijms20010057

Table 1.

Clinical characteristics of ulcerative colitis patients.

Variable Patients with Active Disease Patients in Remission
Biopsies Taken from both Active and Inactive Regions Biopsies Taken from Active Regions only Biopsies Taken from Inactive Regions
Patients, n 30 4 10
Age (years) 50 ± 18 39 ± 21 49 ± 11
Gender
female 16 2 6
male 14 2 4
Smoker, n (%) 1 (3) 0 1 (10)
Disease extent *
Proctitis only 7 (23) - -
Proctosigmoiditis 14 (47) - -
Left-sided colitis 8 (27) - -
Pancolitis 1 (3) 4 (100) 4 (100)
Current Medication for UC
Untreated 12 (40) 2 (50) 3 (30)
Aminosalicylates (5-ASA) 16 (53) 1 (25) 5 (50)
Corticosteroids 6 (20) 2 (50) 3 (30)
Immunomodulator therapy 4 (13) - -
Topical therapy 0 - -
Biologic therapy 0 - -
Antibiotics/probiotics/vitamin supplements 6 - 1

Age and disease duration data are shown as mean value ± SD. Other data indicates the number of patients. Group percentages are shown in brackets. * Disease Extent: Proctitis: Disease only in the rectum; Proctosigmoiditis: Disease in the rectum and sigmoid colon; Left-sided colitis: Limited or distal colitis. Disease in left side of the colon; Pancolitis: Disease in the entire colon.